These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9009147)

  • 1. Extreme N terminus of E1A oncoprotein specifically associates with a new set of cellular proteins.
    Sang N; Giordano A
    J Cell Physiol; 1997 Feb; 170(2):182-91. PubMed ID: 9009147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transactivation of the human cdc2 promoter by adenovirus E1A in cycling cells is mediated by induction of a 110-kDa CCAAT-box-binding factor.
    Tanimoto A; Chen H; Kao CY; Moran E; Sasaguri Y; Padmanabhan R
    Oncogene; 1998 Dec; 17(24):3103-14. PubMed ID: 9872326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deregulation of p53/p21Cip1/Waf1 pathway contributes to polyploidy and apoptosis of E1A+cHa-ras transformed cells after gamma-irradiation.
    Bulavin DV; Tararova ND; Aksenov ND; Pospelov VA; Pospelova TV
    Oncogene; 1999 Oct; 18(41):5611-9. PubMed ID: 10523840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of p53-mediated transactivation and cell cycle arrest by E1A through its p300/CBP-interacting region.
    Somasundaram K; El-Deiry WS
    Oncogene; 1997 Mar; 14(9):1047-57. PubMed ID: 9070653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual action of the adenovirus E1A 243R oncoprotein on the human proliferating cell nuclear antigen promoter: repression of transcriptional activation by p53.
    Kannabiran C; Morris GF; Mathews MB
    Oncogene; 1999 Dec; 18(54):7825-33. PubMed ID: 10618724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway.
    Rousseau D; Cannella D; Boulaire J; Fitzgerald P; Fotedar A; Fotedar R
    Oncogene; 1999 May; 18(21):3290-302. PubMed ID: 10359535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of p300, pocket proteins, and hTBP in E1A-mediated transcriptional regulation and inhibition of p53 transactivation activity.
    Sang N; Avantaggiati ML; Giordano A
    J Cell Biochem; 1997 Sep; 66(3):277-85. PubMed ID: 9257185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping of adenovirus 5 E1A domains responsible for suppression of neu-mediated transformation via transcriptional repression of neu.
    Chen H; Yu D; Chinnadurai G; Karunagaran D; Hung MC
    Oncogene; 1997 Apr; 14(16):1965-71. PubMed ID: 9150363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E1A modulates phosphorylation of p130 and p107 by differentially regulating the activity of G1/S cyclin/CDK complexes.
    Parreño M; Garriga J; Limón A; Albrecht JH; Graña X
    Oncogene; 2001 Aug; 20(35):4793-806. PubMed ID: 11521191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential activation of cyclin and cyclin-dependent kinase genes by adenovirus E1A12S cDNA product.
    Ishii T; Shimizu M; Kanayama Y; Nakada S; Nojima H; Oda K
    Exp Cell Res; 1993 Oct; 208(2):407-14. PubMed ID: 8375470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of binding domains on the p21Cip1 cyclin-dependent kinase inhibitor.
    Goubin F; Ducommun B
    Oncogene; 1995 Jun; 10(12):2281-7. PubMed ID: 7784076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A.
    Yang XJ; Ogryzko VV; Nishikawa J; Howard BH; Nakatani Y
    Nature; 1996 Jul; 382(6589):319-24. PubMed ID: 8684459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of p21Cip1/Waf1 peptide domains required for cyclin E/Cdk2 and PCNA interaction.
    Chen IT; Akamatsu M; Smith ML; Lung FD; Duba D; Roller PP; Fornace AJ; O'Connor PM
    Oncogene; 1996 Feb; 12(3):595-607. PubMed ID: 8637717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Transfection with the E1A and E1B-19kDa oncogenes does not prevent rat embryo fibroblasts from cell cycle arrest after gamma-radiation].
    Bulavin DV; Tararova ND; Brichkina AI; Aksenova ND; Pospelov VA; Pospelova TV
    Mol Biol (Mosk); 2002; 36(1):58-65. PubMed ID: 11862714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of a novel form of p21Cip1/Waf1 in UV-irradiated and transformed cells.
    Poon RY; Hunter T
    Oncogene; 1998 Mar; 16(10):1333-43. PubMed ID: 9546435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of the human cdk2 gene that encodes the cyclin A- and adenovirus E1A-associated p33 kinase.
    Tsai LH; Harlow E; Meyerson M
    Nature; 1991 Sep; 353(6340):174-7. PubMed ID: 1653904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin-dependent kinases phosphorylate the adenovirus E1A protein, enhancing its ability to bind pRb and disrupt pRb-E2F complexes.
    Mal A; Piotrkowski A; Harter ML
    J Virol; 1996 May; 70(5):2911-21. PubMed ID: 8627766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ability of E1A to rescue ras-induced premature senescence and confer transformation relies on inactivation of both p300/CBP and Rb family proteins.
    Deng Q; Li Y; Tedesco D; Liao R; Fuhrmann G; Sun P
    Cancer Res; 2005 Sep; 65(18):8298-307. PubMed ID: 16166306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of distinct roles for separate E1A domains in disruption of E2F complexes.
    Ikeda MA; Nevins JR
    Mol Cell Biol; 1993 Nov; 13(11):7029-35. PubMed ID: 8413292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel E1A domain mediates skeletal-muscle-specific enhancer repression independently of pRB and p300 binding.
    Sandmöller A; Meents H; Arnold HH
    Mol Cell Biol; 1996 Oct; 16(10):5846-56. PubMed ID: 8816499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.